3 results Ā· Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsNeoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-08-06NCT05232916
Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, paraganglioma, pheochromocytoma, primitive neuroectodermal tumorNot yet recruitingNot stated2026-07-17NCT07538791
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System PacingArrhythmias, Cardiac, Bites and Stings, Bradycardia, Cardiac Conduction System Disease, Chemically-Induced Disorders, Fascicular Block, Left Bundle-Branch Block, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, Ventricular Dysfunction, atrial fibrillation, atrioventricular block, atrioventricular dissociation, cardiovascular disorder, heart disorder, heart failure, injury, poisoning, progressive familial heart block, type 1A, systolic heart failure, third-degree atrioventricular block, ventricular fibrillation, ventricular tachycardiaRecruitingNot stated2024-03-22NCT06324682